SCR-LIP-000634 · Claim · machine-readable JSON →
Macrophages in lipedema tissue are reported to show a predominantly alternatively activated, anti-inflammatory phenotype rather than a classical pro-inflammatory one.
General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 6 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (6)
- A distinct M2 macrophage infiltrate and transcriptomic profile decisively influence adipocyte differentiation in lipedema — Wolf et al. (2022) ✓ verified — consistent · basic science · 2022 · risk of bias: moderate · reading confidence: high
Gluteofemoral tissue showed dominant M2 signature with CD163+ enrichment (2.58-fold; 1171 DEGs), while M1 genes (IL1b, IL6, TNFAIP8, TLR4) were downregulated.
Wolf et al.; CyTOF + RNA-seq; in vitro functional causality (IPI-549) - Transcriptomics of Subcutaneous Tissue of Lipedema Identified Differentially Expressed Genes Involved in Adipogenesis, Inflammation, and Pain — Streubel et al. (2024) ✓ verified — consistent · cross sectional · 2024 · reading confidence: high
“Inflamação/macrófagos M2 (upregulated): MAFB, C1Q, C2, CD68, CD209, CD163, CD84, BCAT1, TREM2, MRC1, F13A1, NTRK3 — perfil claramente polarizado para M2 (CD163+/CD209+/MRC1+) sustentando inflamação crônica de baixo grau”
Whole-transcriptome analysis found upregulated M2-associated genes (CD163, CD209, MRC1, TREM2, C1Q) and pain-transmission genes (SCN7A, SLC12A2), distinguishing lipedema from hypertrophied adipose tissue.
Whole transcriptome analysis directly addresses inflammation and pain mechanisms in lipedema tissue by identifying specific differentially expressed genes; limited by small sample sizes per stage and lack of functional validation. - Lipedema and adipose tissue: current understanding, controversies, and future directions — Rabiee (2025) ✓ verified — consistent · review · 2025 · reading confidence: moderate
“estágios avançados exibem crown-like structures de adipócitos necróticos circundados por macrófagos CD68+ e proliferação de células-tronco derivadas do tecido adiposo”
Review reports M2 macrophage predominance in lipedema, contrasting with the M1 response of obesity, with stage-dependent hypertrophy and progressive fibrosis.
This is a narrative mini-review synthesizing current literature on lipedema adipose tissue biology. It directly addresses inflammation mechanisms in lipedema tissue, characterizing the inflammatory profile and distinguishing it from obesity - New Frontiers in modeling the lipedema microenvironment in vitro — Soni & Abbott (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“Macrófagos M2 (CD163+, CD206+): aumento significativo em lipedema — distinto da obesidade (predominância M1) e linfedema (predomínio T cells)”
Review reports significant M2 (CD163+, CD206+) increase and crown-like structures across stages, noting one transcriptomic study (n=14) found suppressed inflammation.
The review directly addresses inflammatory mechanisms in lipedema tissue, describing M2 macrophage infiltration, crown-like structures, and fibrosis, while noting a contradictory transcriptomic finding and acknowledging gaps in understandin - Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis — Kruppa et al. (2023) ✓ verified — refining · cross sectional · 2023 · reading confidence: high
Stage-stratified biopsies: M2-dominant polarization at stage I shifting toward M1-like at stage III; IL6, TNF, VEGFC upregulated at stages II-III; crown-like structures at all stages; fibrosis precedes hypertrophy.
This is a cross-sectional biopsy study with histological, immunohistochemical, and gene expression analyses comparing lipedema stages to controls; it directly characterizes inflammatory mediators, macrophage phenotypes, fibrosis, and molecu - Lipedema: A Disease Triggered by M2 Polarized Macrophages? — Grewal et al. (2025) ✓ verified — refining · review · 2025 · reading confidence: high
“marcadores inflamatórios e oxidativos (CRP normal, mas TNFSF14, S100-A12, MDA elevados em estágio 3)”
Review frames lipedema as M2-macrophage-driven; CRP normal but TNFSF14, S100-A12 and MDA elevated in stage 3.
This comprehensive narrative review directly addresses inflammation and pain mechanisms in lipedema tissue, highlighting the anti-inflammatory M2 macrophage phenotype (rather than classical pro-inflammatory pathways) and vascular permeabili
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000011